1 INTRODUCTION 43
1.1 STUDY OBJECTIVES 43
1.1.1 MARKET DEFINITION 43
1.2 MARKET SCOPE 44
1.2.1 MARKET SEGMENTATION 44
FIGURE 1 NUTRACEUTICAL EXCIPIENTS MARKET SEGMENTATION 44
1.2.2 INCLUSIONS & EXCLUSIONS 45
TABLE 1 NUTRACEUTICAL EXCIPIENTS MARKET: INCLUSIONS & EXCLUSIONS 45
1.2.3 REGIONS COVERED 46
1.3 YEARS CONSIDERED 47
1.4 CURRENCY CONSIDERED 47
TABLE 2 USD EXCHANGE RATES CONSIDERED, 2019–2022 48
1.5 STAKEHOLDERS 48
1.6 SUMMARY OF CHANGES 49
1.6.1 RECESSION IMPACT ANALYSIS 49
2 RESEARCH METHODOLOGY 50
2.1 RESEARCH DATA 50
FIGURE 2 NUTRACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN 50
2.1.1 SECONDARY DATA 51
2.1.1.1 Key data from secondary sources 51
2.1.2 PRIMARY DATA 51
2.1.2.1 Key data from primary sources 52
2.1.2.2 Key insights from industry experts 53
2.1.2.3 Breakdown of primary profiles 53
2.2 MARKET SIZE ESTIMATION 54
FIGURE 3 BOTTOM-UP APPROACH 54
FIGURE 4 TOP-DOWN APPROACH 55
2.3 DATA TRIANGULATION 56
FIGURE 5 DATA TRIANGULATION AND MARKET BREAKUP 56
2.4 ASSUMPTIONS 57
2.5 RESEARCH LIMITATIONS & ASSOCIATED RISKS 58
2.6 RECESSION IMPACT ANALYSIS 58
2.7 RECESSION MACRO-INDICATORS 59
FIGURE 6 RECESSION MACRO-INDICATORS 59
FIGURE 7 GLOBAL INFLATION RATE, 2011–2022 60
FIGURE 8 GLOBAL GDP, 2011–2022 (USD TRILLION) 61
FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON NUTRACEUTICAL EXCIPIENTS MARKET 62
FIGURE 10 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET: EARLIER FORECAST VS. RECESSION FORECAST 62
3 EXECUTIVE SUMMARY 64
TABLE 3 NUTRACEUTICAL EXCIPIENTS MARKET SNAPSHOT, 2023 VS. 2028 64
FIGURE 11 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023 VS. 2028 (USD MILLION) 66
FIGURE 12 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023 VS. 2028 (USD MILLION) 66
FIGURE 13 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION) 67
FIGURE 14 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023 VS. 2028 (USD MILLION) 68
FIGURE 15 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023 VS. 2028 (USD MILLION) 68
FIGURE 16 NUTRACEUTICAL EXCIPIENTS MARKET: REGIONAL SNAPSHOT 69
4 PREMIUM INSIGHTS 70
4.1 BRIEF OVERVIEW OF NUTRACEUTICAL EXCIPIENTS MARKET 70
FIGURE 17 HEALTH-CONSCIOUS CONSUMERS, PREVENTIVE HEALTHCARE, AND PERSONALIZED NUTRITION TRENDS TO DRIVE MARKET GROWTH 70
4.2 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY AND KEY COUNTRY 71
FIGURE 18 COATING AGENTS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET IN 2022 71
4.3 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 71
FIGURE 19 NORTH AMERICA TO DOMINATE NUTRACEUTICAL EXCIPIENTS MARKET FROM 2023 TO 2028 (USD MILLION) 71
4.4 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 72
FIGURE 20 DRY SEGMENT ESTIMATED TO BE LARGEST THROUGHOUT FORECAST PERIOD (USD MILLION) 72
4.5 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE 72
FIGURE 21 ORGANIC CHEMICALS TO BE LARGEST SEGMENT DURING FORECAST PERIOD (USD MILLION) 72
4.6 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION 73
FIGURE 22 MODIFIED RELEASE TO HOLD LARGEST SHARE IN NUTRACEUTICAL EXCIPIENTS MARKET DURING FORECAST PERIOD (USD MILLION) 73
4.7 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT 73
FIGURE 23 PROBIOTICS TO BE LARGEST SEGMENT DURING FORECAST PERIOD (USD MILLION) 73
FIGURE 24 CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGH RATES DURING FORECAST PERIOD 74
5 MARKET OVERVIEW 75
5.1 INTRODUCTION 75
5.2 MACROECONOMIC INDICATORS 75
5.2.1 GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY 75
5.2.2 AGING POPULATION BECOMING MORE AWARE OF BENEFITS OF NUTRACEUTICALS 76
FIGURE 25 US POPULATION AGED 65 AND OLDER, 2000–2060 (MILLION) 77
5.3 MARKET DYNAMICS 78
FIGURE 26 NUTRACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 78
5.3.1 DRIVERS 78
5.3.1.1 Increased focus on preventive care to encourage investments in products/solutions 78
FIGURE 27 NUMBER OF AMERICANS WITH CHRONIC CONDITIONS 79
5.3.1.2 Advancements in nanotechnology equipped with new features relating to nutraceutical excipients 80
5.3.1.3 Rise in demand for fortified food products due to increased health consciousness 80
5.3.1.4 Mandates on food fortification by government organizations 81
TABLE 4 PREVALENCE OF THREE MAJOR MICRONUTRIENT DEFICIENCIES, BY REGION 81
5.3.2 RESTRAINTS 82
5.3.2.1 Decrease in returns on R&D investments and high costs of clinical trials and registration 82
5.3.3 OPPORTUNITIES 83
5.3.3.1 Multi-functionalities of excipients aiding in saving costs and processing time 83
5.3.3.2 Rising awareness of micronutrient deficiencies 84
5.3.4 CHALLENGES 85
5.3.4.1 Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumers’ perception of dietary supplements as pharmaceutical drugs 85
6 INDUSTRY TRENDS 86
6.1 INTRODUCTION 86
6.2 VALUE CHAIN ANALYSIS 86
FIGURE 28 NUTRACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS 86
6.2.1 SOURCING OF RAW MATERIALS 87
6.2.2 MANUFACTURING 87
6.2.3 DISTRIBUTION, MARKETING, AND SALES 87
6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 87
FIGURE 29 REVENUE SHIFT FOR NUTRACEUTICAL EXCIPIENTS MARKET 88
6.4 TECHNOLOGY ANALYSIS 88
6.4.1 FOOD MICROENCAPSULATION 88
6.4.1.1 Encapsulation of omega-3 to mask odor 89
6.4.2 INNOVATIVE AND DISRUPTIVE TECH 89
6.4.2.1 Robotics as key technological trend to lead to innovations 89
6.4.2.2 3D printing to uplift future of nutraceutical excipients market with high-end products 89
6.5 PRICING ANALYSIS 90
FIGURE 30 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2019–2022 (USD/TON) 90
TABLE 5 NORTH AMERICA: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON) 91
TABLE 6 EUROPE: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON) 91
TABLE 7 ASIA PACIFIC: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON) 91
TABLE 8 SOUTH AMERICA: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON) 92
TABLE 9 ROW: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018–2022 (USD/TON) 92
6.6 PATENT ANALYSIS 93
FIGURE 31 LIST OF MAJOR PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS 93
FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2012–2022 94
6.6.1 LIST OF MAJOR PATENTS 94
6.7 ECOSYSTEM/MARKET MAP 95
6.7.1 UPSTREAM 95
6.7.1.1 Excipient Manufacturers 95
6.7.1.2 Technology Providers 95
6.7.2 DOWNSTREAM 96
6.7.2.1 Regulatory Bodies 96
6.7.2.2 Nutraceutical Manufacturers 96
FIGURE 33 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM 97
TABLE 10 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM 97
6.8 TRADE SCENARIO 99
TABLE 11 IMPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME) 99
TABLE 12 EXPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME) 100
TABLE 13 IMPORT DATA OF AMINO ACIDS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME) 101
TABLE 14 EXPORT DATA OF AMINO ACIDS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME) 102
6.9 KEY CONFERENCES & EVENTS, 2023–2024 103
TABLE 15 NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2023–2024 103
6.10 TARIFF AND REGULATORY LANDSCAPE 104
6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 104
TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 107
TABLE 19 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108
TABLE 20 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108
6.10.2 REGULATORY FRAMEWORK 108
6.10.2.1 ORGANIZATIONS/REGULATIONS GOVERNING NUTRACEUTICAL EXCIPIENTS MARKET 108
TABLE 21 DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL EXCIPIENTS WORLDWIDE 109
6.10.2.2 North America 110
6.10.2.2.1 Canada 110
6.10.2.2.2 US 110
6.10.2.2.3 Mexico 110
6.10.2.3 European Union (EU) 110
6.10.2.4 Asia Pacific 111
6.10.2.4.1 Japan 111
6.10.2.4.2 China 111
6.10.2.4.3 India 111
6.10.2.4.4 Australia & New Zealand 111
6.10.2.5 Rest of the World (RoW) 112
6.10.2.5.1 Israel 112
6.10.2.5.2 Brazil 112
6.10.2.6 Probiotics 112
6.10.2.6.1 Introduction 112
6.10.2.6.2 National/International bodies for safety standards and regulations 112
TABLE 22 DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE 112
6.10.2.6.3 Codex alimentarius commission (CAC) 113
6.10.2.6.4 North America: regulatory environment analysis 113
6.10.2.6.4.1 US 113
6.10.2.6.4.2 Canada 114
6.10.2.6.5 Asia Pacific: Regulatory environment analysis 115
6.10.2.6.5.1 Japan 115
6.10.2.6.5.2 India 116
6.10.2.6.6 South America: Regulatory Environment Analysis 116
6.10.2.6.6.1 Brazil 116
6.10.2.7 PREBIOTICS 116
6.10.2.7.1 Introduction 116
6.10.2.7.2 Asia Pacific 117
6.10.2.7.2.1 Japan 117
6.10.2.7.2.2 Australia & New Zealand 117
6.10.2.7.2.3 South Korea 117
6.10.2.7.2.4 India 117
TABLE 23 SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS, 2015, FOR LIST OF APPROVED PREBIOTIC EXCIPIENTS 117
6.10.2.7.3 North America 118
6.10.2.7.3.1 US 118
6.10.2.7.3.2 Canada 118
TABLE 24 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES 118
6.10.2.7.4 European Union 119
6.11 PORTER’S FIVE FORCES ANALYSIS 119
TABLE 25 PORTER’S FIVE FORCES IMPACT ON NUTRACEUTICAL EXCIPIENTS MARKET 119
6.11.1 INTENSITY OF COMPETITIVE RIVALRY 120
6.11.2 BARGAINING POWER OF SUPPLIERS 120
6.11.3 BARGAINING POWER OF BUYERS 121
6.11.4 THREAT OF SUBSTITUTES 121
6.11.5 THREAT OF NEW ENTRANTS 121
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 122
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 122
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 TYPES 122
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 PRODUCT SOURCES (%) 122
6.12.2 BUYING CRITERIA 123
TABLE 27 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR FOR TOP 3 TYPES 123
FIGURE 35 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR FOR TOP 3 TYPES 123
6.13 CASE STUDY ANALYSIS 124
6.13.1 USE CASE 1: FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY 124
6.13.2 USE CASE 2: EXCIPIENTS OF CHOICE FOR TASTE MASKING TECHNOLOGY WITH HOT MELT EXTRUSION 124
7 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE 125
7.1 INTRODUCTION 126
FIGURE 36 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023 VS. 2028 (USD MILLION) 126
7.2 ORGANIC CHEMICALS 126
TABLE 28 ORGANIC EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 127
TABLE 29 ORGANIC EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 127
TABLE 30 ORGANIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2018–2022 (USD MILLION) 127
TABLE 31 ORGANIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2023–2028 (USD MILLION) 128
7.2.1 OLEOCHEMICALS 128
TABLE 32 OLEOCHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION) 128
TABLE 33 OLEOCHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION) 128
7.2.1.1 Fatty alcohols 129
7.2.1.1.1 Need for enhancing texture and creaminess likely to propel demand 129
7.2.1.2 Mineral stearates 129
7.2.1.2.1 Mineral stearates to reduce friction and avoid equipment clogging during manufacturing of nutraceuticals 129
7.2.1.3 Glycerin 129
7.2.1.3.1 Glycerin to help improve smoothness and lubrication process 129
7.2.1.4 Other oleochemicals 130
7.2.2 CARBOHYDRATES 130
TABLE 34 CARBOHYDRATES: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION) 130
TABLE 35 CARBOHYDRATES: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION) 130
7.2.2.1 Sugars 131
TABLE 36 SUGARS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION) 131
TABLE 37 SUGARS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION) 131
7.2.2.1.1 Actual sugars 131
7.2.2.1.1.1 Rising diabetic population to fuel need for low-glycemic index alternatives like xylitol and isomaltulose 131
7.2.2.1.2 Sugar alcohols 132
7.2.2.1.2.1 Various advantageous and unique properties of sugar alcohols to make them attractive option 132
7.2.2.1.3 Artificial sweeteners 132
7.2.2.1.3.1 Emerging trends in utilization of natural sweeteners in nutraceutical products to drive demand 132
7.2.2.2 Cellulose 133
TABLE 38 CELLULOSE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION) 133
TABLE 39 CELLULOSE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION) 134
7.2.2.2.1 Microcrystalline cellulose 134
7.2.2.2.1.1 Rising nutraceutical trend to bolster microcrystalline cellulose demand for superior tablet integrity 134
7.2.2.2.2 Cellulose ethers 134
7.2.2.2.2.1 Cellulose ethers help streamline nutraceutical rheology 134
7.2.2.2.3 CMC & croscarmellose sodium 135
7.2.2.2.3.1 Enhanced mouthfeel and fast-acting properties to help propel market growth 135
7.2.2.2.4 Cellulose esters 136
7.2.2.2.4.1 Rising demand for cellulose esters to provide technical edge in nutraceuticals 136
7.2.2.3 Starch 136
TABLE 40 STARCH: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION) 136
TABLE 41 STARCH: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION) 136
7.2.2.3.1 Modified starch 137
7.2.2.3.1.1 Technical advancements to fuel modified starch demand in nutraceuticals excipients industry 137
7.2.2.3.2 Dried starch 137
7.2.2.3.2.1 Capabilities such as disintegration enhancement and bulking effects to drive market 137
7.2.2.3.3 Converted starch 137
7.2.2.3.3.1 Properties such as increased solubility to boost nutrient absorption 137
7.2.3 PETROCHEMICALS 138
TABLE 42 PETROCHEMICALS EXCIPIENTS MARKET, BY, SUBTYPE, 2018–2022 (USD MILLION) 138
TABLE 43 PETROCHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION) 139
7.2.3.1 Glycols 139
7.2.3.1.1 Humectant & solvent properties to drive demand 139
7.2.3.2 Povidones 139
7.2.3.2.1 Film-forming function to provide controlled release of active ingredients 139
7.2.3.3 Mineral hydrocarbons 140
7.2.3.3.1 Properties such as anti-foaming & lubrication to help in nutraceutical manufacturing 140
7.2.3.4 Acrylic polymers 140
7.2.3.4.1 Diverse functions of acrylic polymers in nutraceuticals to propel growth 140
7.2.3.5 Other petrochemical excipients 140
7.2.4 PROTEINS 140
7.2.4.1 Expanding utilization of proteins as carriers for microparticles and nanoparticles to propel market growth 140
7.2.5 OTHER ORGANIC CHEMICALS 141
7.3 INORGANIC CHEMICALS 141
TABLE 44 INORGANIC EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 141
TABLE 45 INORGANIC EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 141
TABLE 46 INORGANIC CHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2018–2022 (USD MILLION) 142
TABLE 47 INORGANIC CHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2023–2028 (USD MILLION) 142
7.3.1 CALCIUM PHOSPHATE 142
7.3.1.1 Nutraceutical production to be optimized by utilizing GMO-free calcium phosphates as GRAS excipients 142
7.3.2 METAL OXIDES 143
7.3.2.1 Metal oxides to help meet rising demand for iron-enriched nutraceuticals 143
7.3.3 HALITES 143
7.3.3.1 Halites to ensure taste improvement and salting-out techniques 143
7.3.4 CALCIUM CARBONATE 144
7.3.4.1 Focus on R&D of calcium carbonate to help launch new products 144
7.3.5 CALCIUM SULFATE 144
7.3.5.1 Improved flowability to drive demand for calcium sulfate 144
7.3.6 OTHER INORGANIC CHEMICALS 144
7.4 OTHER CHEMICALS 145
TABLE 48 OTHER CHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 145
TABLE 49 OTHER CHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 145
8 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT 146
8.1 INTRODUCTION 147
TABLE 50 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION) 148
TABLE 51 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION) 148
FIGURE 37 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023 VS. 2028 149
8.2 PROBIOTICS 149
8.2.1 INCREASING INCLINATION OF CONSUMERS TOWARD IMMUNITY-ENHANCING PRODUCTS POST-COVID-19 TO DRIVE MARKET GROWTH 149
TABLE 52 PROBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 150
TABLE 53 PROBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 150
8.3 PREBIOTICS 151
8.3.1 INCREASE IN DIGESTIVE ISSUES AMONG CONSUMERS RESULTING IN ACIDITY AND INFLAMMATORY ISSUES, TO ENCOURAGE CONSUMPTION OF PREBIOTICS AS PREVENTIVE MEASURE 151
TABLE 54 PREBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 151
TABLE 55 PREBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 151
8.4 PROTEINS & AMINO ACIDS 152
8.4.1 INCREASED POPULARITY OF PROTEINS AND AMINO ACIDS AMONG YOUTH TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET 152
TABLE 56 PROTEINS & AMINO ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 152
TABLE 57 PROTEINS & AMINO ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 152
8.5 VITAMINS 153
8.5.1 PREVALENCE OF VITAMIN DEFICIENCIES AMONG CONSUMERS TO DRIVE MARKET GROWTH FOR NUTRACEUTICAL EXCIPIENTS 153
TABLE 58 VITAMINS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 153
TABLE 59 VITAMINS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 153
TABLE 60 LIST OF NUTRIENTS AND THEIR RELEVANCE 154
8.6 MINERALS 154
8.6.1 BENEFITS OFFERED FOR OPTIMAL FUNCTIONING OF BRAIN AND HEART TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET 154
TABLE 61 MINERALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 155
TABLE 62 MINERALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 155
8.7 OMEGA-3 FATTY ACIDS 155
8.7.1 INCREASE IN HEART DISEASES TO DRIVE DEMAND FOR OMEGA-3 FATTY ACIDS SUPPLEMENTS 155
TABLE 63 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 156
TABLE 64 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 156
8.8 OTHER END PRODUCTS 157
TABLE 65 OTHER END PRODUCTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 157
TABLE 66 OTHER END PRODUCTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 157
9 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 158
9.1 INTRODUCTION 159
TABLE 67 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION) 159
TABLE 68 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION) 159
FIGURE 38 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023 VS. 2028 160
9.2 DRY 160
TABLE 69 DRY: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 161
TABLE 70 DRY: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 161
9.2.1 TABLETS 161
9.2.1.1 Easy to carry and portable nature to make them attractive option 161
9.2.2 CAPSULES 162
9.2.2.1 Quick-dissolving capsule shells for targeted absorption to be ideal for nutraceuticals designed to act in specific areas of digestive tract 162
9.3 LIQUID 162
9.3.1 POTENTIAL GROWTH OPPORTUNITIES FOR LIQUID NUTRACEUTICAL EXCIPIENTS DUE TO INNOVATIONS IN FORMULATIONS TO DRIVE GROWTH 162
TABLE 71 LIQUID: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 162
TABLE 72 LIQUID: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 163
9.4 OTHER FORMULATIONS 163
TABLE 73 OTHER FORMULATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 163
TABLE 74 OTHER FORMULATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 164
10 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY 165
10.1 INTRODUCTION 166
TABLE 75 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 167
TABLE 76 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 167
FIGURE 39 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023 VS. 2028 168
10.2 BINDERS 168
10.2.1 INCREASED ACCEPTABILITY AND USE OF BINDING AGENTS IN PRODUCTS TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET 168
TABLE 77 BINDERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 169
TABLE 78 BINDERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 169
10.3 FILLERS & DILUENTS 170
10.3.1 USE OF ACTIVE INGREDIENTS IN NUTRACEUTICAL PRODUCTS TO ENCOURAGE USE OF FILLERS AND DILUENTS AS EXCIPIENTS 170
TABLE 79 FILLERS & DILUENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 170
TABLE 80 FILLERS & DILUENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 170
10.4 DISINTEGRANTS 171
10.4.1 HIGH CONSUMPTION OF DIETARY SUPPLEMENTS IN FORM OF ORAL DOSAGES OR TABLETS TO DRIVE GROWTH OF DISINTEGRANTS SEGMENT 171
TABLE 81 DISINTEGRANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 171
TABLE 82 DISINTEGRANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 172
10.5 COATING AGENTS 172
10.5.1 PROTECTION FROM MOISTURE AND BACTERIA TO DRIVE DEMAND 172
TABLE 83 COATING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 172
TABLE 84 COATING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 173
10.6 FLAVORING AGENTS & SWEETENERS 173
10.6.1 INCREASE IN NEED FOR MASKING STRONG AND UNAPPEALING FLAVORS TO DRIVE GROWTH OF SEGMENT 173
TABLE 85 FLAVORING AGENTS & SWEETENERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 173
TABLE 86 FLAVORING AGENTS & SWEETENERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 174
10.7 PRESERVATIVES 174
10.7.1 INHIBITION OF MICROBIAL GROWTH AND MAINTAINING PRODUCT QUALITY AND SAFETY TO DRIVE DEMAND FOR PRESERVATIVES 174
TABLE 87 PRESERVATIVES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 174
TABLE 88 PRESERVATIVES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 175
10.8 LUBRICANTS & GLIDANTS 175
10.8.1 INCREASE IN NEED FOR REDUCING FRICTION AND KEEPING FORMULATION INTACT DURING PRODUCTION PROCESS TO DRIVE GROWTH OF SEGMENT 175
TABLE 89 LUBRICANTS & GLIDANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 175
TABLE 90 LUBRICANTS & GLIDANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 176
10.9 SUSPENDING & VISCOSITY AGENTS 176
10.9.1 PREVENTING SETTLING TO HELP MAINTAIN HOMOGENEITY AND STABILITY OF PRODUCT 176
TABLE 91 SUSPENDING & VISCOSITY AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 176
TABLE 92 SUSPENDING & VISCOSITY AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 177
10.10 COLORANTS 177
10.10.1 NEED FOR VISUAL APPEAL AND PRODUCT DIFFERENTIATION TO FUEL DEMAND FOR COLORANTS 177
TABLE 93 COLORANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 177
TABLE 94 COLORANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 178
10.11 EMULSIFYING AGENTS 178
10.11.1 NEED FOR REDUCING SURFACE TENSION BETWEEN DIFFERENT COMPONENTS TO DRIVE DEMAND FOR EMULSIFYING AGENTS 178
TABLE 95 EMULSIFYING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 178
TABLE 96 EMULSIFYING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 179
10.12 OTHER FUNCTIONALITIES 179
TABLE 97 OTHER FUNCTIONALITIES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 179
TABLE 98 OTHER FUNCTIONALITIES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 180
11 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION 181
11.1 INTRODUCTION 182
TABLE 99 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION) 182
TABLE 100 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATI0N, 2023–2028 (USD MILLION) 182
FIGURE 40 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023 VS. 2028 183
11.2 TASTE MASKING 183
11.2.1 CREATING DIFFERENTIATION TO BE KEY IN THIS COMPETITIVE MARKET 183
TABLE 101 TASTE MASKING: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 184
TABLE 102 TASTE MASKING: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 184
11.3 STABILIZERS 184
11.3.1 MAINTAINING DESIRABLE PROPERTIES UNTIL CONSUMPTION TO DRIVE DEMAND FOR STABILIZERS 184
TABLE 103 STABILIZERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 185
TABLE 104 STABILIZERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 185
11.4 MODIFIED RELEASE 185
11.4.1 NEED FOR SLOWER AND STEADIER RELEASE OF COMPOUNDS TO PROPEL GROWTH OF MODIFIED-RELEASE APPLICATION IN NUTRACEUTICAL EXCIPIENTS MARKET 185
TABLE 105 MODIFIED RELEASE: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 186
TABLE 106 MODIFIED RELEASE: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 186
11.5 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT 186
11.5.1 CHALLENGES RELATED TO POOR SOLUBILITY AND LIMITED ABSORPTION OF BIOACTIVE COMPOUNDS TO DRIVE DEMAND 186
TABLE 107 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 187
TABLE 108 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 187
11.6 OTHER FUNCTIONALITY APPLICATIONS 187
TABLE 109 OTHER FUNCTIONALITY APPLICATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 188
TABLE 110 OTHER FUNCTIONALITY APPLICATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 188
12 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION 189
12.1 INTRODUCTION 190
FIGURE 41 NORTH AMERICA TO BE LARGEST MARKET THROUGHOUT FORECAST PERIOD 191
FIGURE 42 CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 191
TABLE 111 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 192
TABLE 112 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 192
12.2 NORTH AMERICA 192
FIGURE 43 NORTH AMERICA: MARKET SNAPSHOT 193
12.2.1 RECESSION IMPACT ANALYSIS 193
FIGURE 44 NORTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS 194
TABLE 113 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 194
TABLE 114 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 194
TABLE 115 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018–2022 (USD MILLION) 195
TABLE 116 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023–2028 (USD MILLION) 195
TABLE 117 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 195
TABLE 118 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 196
TABLE 119 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION) 196
TABLE 120 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION) 196
TABLE 121 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION) 197
TABLE 122 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION) 197
TABLE 123 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION) 198
TABLE 124 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION) 198
12.2.2 US 198
12.2.2.1 High concentration of key players, various nutrition awareness programs, and increase in preventive healthcare trends in US 198
TABLE 125 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 199
TABLE 126 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 199
12.2.3 CANADA 200
12.2.3.1 Demand for quality and cost-competition: Two key factors for manufacturers to consider in Canada 200
TABLE 127 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 201
TABLE 128 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 201
12.2.4 MEXICO 202
12.2.4.1 Increase in foreign direct investments and rise in awareness regarding healthier lifestyles associated with dietary supplements 202
TABLE 129 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 203
TABLE 130 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 203
12.3 EUROPE 204
12.3.1 RECESSION IMPACT ANALYSIS 204
FIGURE 45 EUROPEAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS 205
TABLE 131 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 205
TABLE 132 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 206
TABLE 133 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018–2022 (USD MILLION) 206
TABLE 134 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023–2028 (USD MILLION) 206
TABLE 135 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 207
TABLE 136 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 207
TABLE 137 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION) 208
TABLE 138 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION) 208
TABLE 139 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION) 208
TABLE 140 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION) 209
TABLE 141 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION) 209
TABLE 142 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION) 209
12.3.2 GERMANY 210
12.3.2.1 Demand for nutraceutical excipients likely to increase to serve health-conscious consumers 210
TABLE 143 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 210
TABLE 144 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 211
12.3.3 FRANCE 211
12.3.3.1 Innovations in product formulations to cater to increased consumer demands 211
TABLE 145 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 212
TABLE 146 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 212
12.3.4 UK 213
12.3.4.1 Growth of functional/fortified food & beverage industry in UK to drive demand for nutraceutical excipients 213
TABLE 147 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 213
TABLE 148 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 214
12.3.5 ITALY 214
12.3.5.1 Growing trend of online OTC and food supplement purchases in Italy 214
TABLE 149 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 215
TABLE 150 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 215
12.3.6 SPAIN 216
12.3.6.1 Growth of food supplements, sports nutrition, and healthcare care markets likely to create favorable environment for nutraceutical excipients 216
TABLE 151 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 216
TABLE 152 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 217
12.3.7 REST OF EUROPE 217
TABLE 153 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 218
TABLE 154 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 218
FIGURE 46 ASIA PACIFIC: MARKET SNAPSHOT 220
12.4.1 RECESSION IMPACT ANALYSIS 220
FIGURE 47 ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS 221
TABLE 155 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 221
TABLE 156 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 222
TABLE 157 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018–2022 (USD MILLION) 222
TABLE 158 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023–2028 (USD MILLION) 222
TABLE 159 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 223
TABLE 160 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 223
TABLE 161 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION) 224
TABLE 162 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION) 224
TABLE 163 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION) 224
TABLE 164 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION) 225
TABLE 165 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION) 225
TABLE 166 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION) 225
12.4.2 CHINA 226
12.4.2.1 Rise in preference for nutraceutical products and innovations in dietary supplement formulations and fortified food products 226
TABLE 167 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 227
TABLE 168 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 227
12.4.3 JAPAN 228
12.4.3.1 Manufacturers should think beyond pills & innovation to tap this growing market in Japan 228
TABLE 169 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 228
TABLE 170 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 229
12.4.4 INDIA 229
12.4.4.1 Government policies and importance of nutraceuticals in daily life 229
TABLE 171 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 230
TABLE 172 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 230
12.4.5 SOUTH KOREA 231
12.4.5.1 Rapid growth of supplements industry in South Korea 231
TABLE 173 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 231
TABLE 174 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 232
12.4.6 REST OF ASIA PACIFIC 232
TABLE 175 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 233
TABLE 176 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 233
12.5 SOUTH AMERICA 234
12.5.1 RECESSION IMPACT ANALYSIS 234
FIGURE 48 SOUTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS 234
TABLE 177 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 235
TABLE 178 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 235
TABLE 179 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018–2022 (USD MILLION) 235
TABLE 180 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023–2028 (USD MILLION) 236
TABLE 181 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 236
TABLE 182 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 237
TABLE 183 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION) 237
TABLE 184 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION) 237
TABLE 185 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION) 238
TABLE 186 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION) 238
TABLE 187 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION) 239
TABLE 188 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION) 239
12.5.2 BRAZIL 239
12.5.2.1 Growth in awareness regarding benefits of functional foods and rise in aging population in Brazil 239
TABLE 189 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 240
TABLE 190 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 240
12.5.3 ARGENTINA 241
12.5.3.1 Country’s focus on prevention healthcare system to be positive sign for nutraceutical excipients market 241
TABLE 191 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 241
TABLE 192 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 242
12.5.4 REST OF SOUTH AMERICA 242
TABLE 193 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 243
TABLE 194 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 243
12.6 REST OF THE WORLD (ROW) 244
12.6.1 RECESSION IMPACT ANALYSIS 244
FIGURE 49 ROW NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS 245
TABLE 195 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 245
TABLE 196 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 245
TABLE 197 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018–2022 (USD MILLION) 245
TABLE 198 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023–2028 (USD MILLION) 246
TABLE 199 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 246
TABLE 200 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 247
TABLE 201 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018–2022 (USD MILLION) 247
TABLE 202 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023–2028 (USD MILLION) 247
TABLE 203 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018–2022 (USD MILLION) 248
TABLE 204 ROW NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023–2028 (USD MILLION) 248
TABLE 205 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018–2022 (USD MILLION) 249
TABLE 206 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023–2028 (USD MILLION) 249
12.6.2 MIDDLE EAST 249
12.6.2.1 Rise in obesity and other health-related concerns in Middle East 249
TABLE 207 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 250
TABLE 208 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 251
12.6.3 AFRICA 251
12.6.3.1 Intra-African trade policies and investments by global nutraceutical players 251
TABLE 209 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018–2022 (USD MILLION) 252
TABLE 210 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023–2028 (USD MILLION) 252
13 COMPETITIVE LANDSCAPE 253
13.1 OVERVIEW 253
13.2 MARKET SHARE ANALYSIS 253
TABLE 211 NUTRACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION, 2022 254
13.3 KEY PLAYER STRATEGIES/RIGHT TO WIN 254
TABLE 212 STRATEGIES ADOPTED BY KEY PLAYERS 254
13.4 REVENUE ANALYSIS 259
FIGURE 50 HISTORICAL REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 (USD BILLION) 259
13.5 KEY PLAYER ANNUAL REVENUE VS. GROWTH 260
FIGURE 51 ANNUAL REVENUE, 2022 (USD BILLION) VS. REVENUE GROWTH, 2020–2022 (%) 260
13.6 KEY PLAYERS’ EBIT/EBITDA 261
FIGURE 52 EBITDA, 2022 (USD BILLION) 261
13.7 GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS 261
FIGURE 53 NUTRACEUTICAL EXCIPIENTS MARKET: GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS, 2022 261
13.8 COMPANY EVALUATION MATRIX (KEY PLAYERS) 262
13.8.1 STARS 262
13.8.2 EMERGING LEADERS 262
13.8.3 PERVASIVE PLAYERS 262
13.8.4 PARTICIPANTS 263
FIGURE 54 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022 263
13.8.5 COMPANY FOOTPRINT 264
TABLE 213 COMPANY FOOTPRINT, BY FUNCTIONALITY 264
TABLE 214 COMPANY FOOTPRINT, BY PRODUCT SOURCE 265
TABLE 215 COMPANY FOOTPRINT, BY REGION 266
TABLE 216 OVERALL COMPANY FOOTPRINT 267
13.9 STARTUP/SME EVALUATION MATRIX 268
13.9.1 PROGRESSIVE COMPANIES 268
13.9.2 RESPONSIVE COMPANIES 268
13.9.3 DYNAMIC COMPANIES 268
13.9.4 STARTING BLOCKS 268
FIGURE 55 STARTUP/SME EVALUATION MATRIX, 2022 269
13.9.5 COMPETITIVE BENCHMARKING 270
TABLE 217 NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 270
TABLE 218 NUTRACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 271
TABLE 219 COMPANY FOOTPRINT, BY FUNCTIONALITY (STARTUPS) 272
13.10 COMPETITIVE SCENARIO 273
13.10.1 NEW PRODUCT LAUNCHES 273
TABLE 220 NUTRACEUTICAL EXCIPIENTS MARKET: NEW PRODUCT LAUNCHES, 2019–2023 273
13.10.2 DEALS 277
TABLE 221 NUTRACEUTICAL EXCIPIENTS MARKET: DEALS, 2019–2023 277
13.10.3 OTHERS 284
TABLE 222 NUTRACEUTICAL EXCIPIENTS MARKET: OTHERS, 2019–2023 284
14 COMPANY PROFILES 289
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
14.1 KEY PLAYERS 289
14.1.1 INTERNATIONAL FLAVORS & FRAGRANCES INC 289
TABLE 223 INTERNATIONAL FLAVORS & FRAGRANCES INC: BUSINESS OVERVIEW 289
FIGURE 56 INTERNATIONAL FLAVORS & FRAGRANCES INC: COMPANY SNAPSHOT 290
TABLE 224 INTERNATIONAL FLAVORS & FRAGRANCES INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 290
TABLE 225 INTERNATIONAL FLAVORS & FRAGRANCES INC: PRODUCT LAUNCHES 292
TABLE 226 INTERNATIONAL FLAVORS & FRAGRANCES INC: DEALS 292
14.1.2 KERRY GROUP PLC 294
TABLE 227 KERRY GROUP PLC: BUSINESS OVERVIEW 294
FIGURE 57 KERRY GROUP PLC: COMPANY SNAPSHOT 295
TABLE 228 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 295
TABLE 229 KERRY GROUP PLC: DEALS 296
14.1.3 INGREDION 298
TABLE 230 INGREDION: BUSINESS OVERVIEW 298
FIGURE 58 INGREDION: COMPANY SNAPSHOT 299
TABLE 231 INGREDION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 300
TABLE 232 INGREDION: DEALS 300
14.1.4 SENSIENT TECHNOLOGIES CORPORATION 302
TABLE 233 SENSIENT TECHNOLOGIES CORPORATION: BUSINESS OVERVIEW 302
FIGURE 59 SENSIENT TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT 303
TABLE 234 SENSIENT TECHNOLOGIES CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 303
TABLE 235 SENSIENT TECHNOLOGIES CORPORATION: DEALS 305
14.1.5 ASSOCIATED BRITISH FOODS PLC 307
TABLE 236 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW 307
FIGURE 60 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT 308
TABLE 237 ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 308
TABLE 238 ASSOCIATED BRITISH FOODS PLC: PRODUCT LAUNCHES 310
14.1.6 BASF SE 312
TABLE 239 BASF SE: BUSINESS OVERVIEW 312
FIGURE 61 BASF SE: COMPANY SNAPSHOT 313
TABLE 240 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 313
TABLE 241 BASF SE: DEALS 315
TABLE 242 BASF SE: OTHERS 315
14.1.7 ROQUETTE FRÈRES 317
TABLE 243 ROQUETTE FRÈRES: BUSINESS OVERVIEW 317
TABLE 244 ROQUETTE FRÈRES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 317
TABLE 245 ROQUETTE FRÈRES: PRODUCT LAUNCHES 319
TABLE 246 ROQUETTE FRÈRES: DEALS 321
TABLE 247 ROQUETTE FRÈRES: OTHERS 322
14.1.8 MEGGLE GROUP GMBH 324
TABLE 248 MEGGLE GROUP GMBH: BUSINESS OVERVIEW 324
TABLE 249 MEGGLE GROUP GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 325
14.1.9 CARGILL, INCORPORATED 327
TABLE 250 CARGILL, INCORPORATED: BUSINESS OVERVIEW 327
FIGURE 62 CARGILL, INCORPORATED: COMPANY SNAPSHOT 327
TABLE 251 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 328
TABLE 252 CARGILL, INCORPORATED: DEALS 330
TABLE 253 CARGILL, INCORPORATED: OTHERS 330
14.1.10 ASHLAND 332
TABLE 254 ASHLAND: BUSINESS OVERVIEW 332
FIGURE 63 ASHLAND: COMPANY SNAPSHOT 333
TABLE 255 ASHLAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED 333
TABLE 256 ASHLAND: PRODUCT LAUNCHES 334
TABLE 257 ASHLAND: OTHERS 335
14.1.11 AZELIS GROUP 336
TABLE 258 AZELIS GROUP: BUSINESS OVERVIEW 336
FIGURE 64 AZELIS GROUP: COMPANY SNAPSHOT 337
TABLE 259 AZELIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 337
TABLE 260 AZELIS GROUP: DEALS 338
TABLE 261 AZELIS GROUP: OTHERS 342
14.1.12 IMCD 344
TABLE 262 IMCD: BUSINESS OVERVIEW 344
FIGURE 65 IMCD: COMPANY SNAPSHOT 345
TABLE 263 IMCD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 345
TABLE 264 IMCD: DEALS 346
TABLE 265 IMCD: OTHERS 348
14.1.13 HILMAR CHEESE COMPANY, INC. 349
TABLE 266 HILMAR CHEESE COMPANY, INC: BUSINESS OVERVIEW 349
TABLE 267 HILMAR CHEESE COMPANY, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 349
14.1.14 SEPPIC 351
TABLE 268 SEPPIC: BUSINESS OVERVIEW 351
TABLE 269 SEPPIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 351
TABLE 270 SEPPIC: PRODUCT LAUNCHES 353
14.1.15 BIOGRUND GMBH 354
TABLE 271 BIOGRUND GMBH: BUSINESS OVERVIEW 354
TABLE 272 BIOGRUND GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 354
14.2 OTHER PLAYERS 356
14.2.1 INNOPHOS 356
TABLE 273 INNOPHOS: BUSINESS OVERVIEW 356
TABLE 274 INNOPHOS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 357
TABLE 275 INNOPHOS: PRODUCT LAUNCHES 357
14.2.2 DAICEL CORPORATION 358
TABLE 276 DAICEL CORPORATION: BUSINESS OVERVIEW 358
FIGURE 66 DAICEL CORPORATION: COMPANY SNAPSHOT 359
TABLE 277 DAICEL CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 359
14.2.3 ALSIANO A/S 361
TABLE 278 ALSIANO A/S: BUSINESS OVERVIEW 361
TABLE 279 ALSIANO A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED 361
14.2.4 JRS PHARMA 364
TABLE 280 JRS PHARMA: BUSINESS OVERVIEW 364
TABLE 281 JRS PHARMA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 364
TABLE 282 JRS PHARMA: OTHERS 366
14.2.5 COLORCON 367
TABLE 283 COLORCON: BUSINESS OVERVIEW 367
TABLE 284 COLORCON: PRODUCTS/SOLUTIONS/SERVICES OFFERED 367
TABLE 285 COLORCON: PRODUCT LAUNCHES 369
TABLE 286 COLORCON: DEALS 370
TABLE 287 COLORCON: OTHERS 370
14.2.6 PANCHAMRUT CHEMICALS 372
TABLE 288 PANCHAMRUT CHEMICALS: BUSINESS OVERVIEW 372
14.2.7 OMYA 373
TABLE 289 OMYA: BUSINESS OVERVIEW 373
14.2.8 GATTEFOSSÉ 374
TABLE 290 GATTEFOSSÉ: BUSINESS OVERVIEW 374
14.2.9 FUJI CHEMICAL INDUSTRIES CO., LTD 375
TABLE 291 FUJI CHEMICAL INDUSTRIES CO., LTD: BUSINESS OVERVIEW 375
14.2.10 JIGS CHEMICAL 376
TABLE 292 JIGS CHEMICAL: BUSINESS OVERVIEW 376
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
15 ADJACENT & RELATED MARKETS 377
15.1 INTRODUCTION 377
15.2 LIMITATIONS 377
15.3 FUNCTIONAL FOOD INGREDIENTS MARKET 378
15.3.1 MARKET DEFINITION 378
15.3.2 MARKET OVERVIEW 378
15.3.3 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE 379
15.3.3.1 Introduction 379
TABLE 293 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 379
TABLE 294 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 380
15.4 NUTRACEUTICAL INGREDIENTS MARKET 380
15.4.1 MARKET DEFINITION 380
15.4.2 MARKET OVERVIEW 380
15.4.3 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE 381
15.4.3.1 Introduction 381
TABLE 295 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (USD MILLION) 381
TABLE 296 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (USD MILLION) 382
TABLE 297 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017–2021 (KT) 382
TABLE 298 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022–2027 (KT) 383
16 APPENDIX 384
16.1 DISCUSSION GUIDE 384
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 388
16.3 CUSTOMIZATION OPTIONS 390
16.4 RELATED REPORTS 390
16.5 AUTHOR DETAILS 391
